Zacks.com on MSN1mon
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Per the data readout, treatment with ARCT-154 showed a stronger and longer-lasting immune response compared with that ...
GlobalData on MSN27d
A slow start for self-amplifying mRNA vaccines
In November 2023, Kostaive (ARCT-154), developed by Arcturus Therapeutics and CSL Behring, was the first samRNA vaccine to ...
pharmaphorum11mon
CSL, Arcturus get first approval for self-assembling RNA jab
The Ministry of Health, Labour and Welfare (MHLW) gave the green light to CSL and Arcturus’ COVID-19 vaccine ARCT-154 – also known as Lunar-COV19 – which will be commercialised in Japan by ...